120
Participants
Start Date
April 30, 2005
Study Completion Date
June 30, 2006
Oralgam (human immunoglobulin)
Strong Center for Developmental Disabilities, University of Rochester Medical Center, Rochester
Merck Child Outpatient Clinic, Pittsburgh
Sarkis Clinical Trials, Gainesville
University of Florida HSC, Gainesville
Medical Research Group of Central Florida, Orange City
International Child Development Resource Center, Melbourne
Bluegrass Clinical Research, Louisville
Nisonger Center Ohio State University, Columbus
Children's Hospital Medical Center of Akron, Akron
Riley Hospital for Children, Indianapolis
Pivotal Research Centers - Detroit, Royal Oak
Mercy Health Research, St Louis
University of Kansas Medical Center, Developmental Disabilities Center, Kansas City
Gulf Coast Research, LLC, Baton Rouge
North San Antonio Healthcare Associates, San Antonio
Southwest Autism Research and Resource Center, Phoenix
Center for Autism Research and Education, Phoenix
University of California Davis, MIND Institute, Sacramento
Autism Spectrum Treatment and Research Center, Seattle
Hardy Health Associates, Hingham
Robert Wood Johnson Medical School, Piscataway
Cincinnati Children's Hospital, Cincinnati
Lead Sponsor
PediaMed Pharmaceuticals
INDUSTRY